Here are a few thoughts from my side, by the way I've only been a shareholder for 7 days today.
Don't get me wrong though, I stay in substantial positions for years at a time.
Since the 9th when we had a rerate, 11,271 million shares have traded hands, that represents 7.8% of the registry.
The top 20 hold 57.24% of the company and I feel for all intents we can say ( They do not sell)
From observation I feel that another 25% of the larger more stable holders will also not sell, They hold perhaps more than 100,000 shares each, they are likely buying to hold.
Those 2 cohorts ( Top 20 + Large stable holders) hold a total of around 82% of the registry.
That leaves 17.76% of the company in free float trading that is being traded aggressively over the past 7 days. 7.8% turned so far.
Some of those free float shares are finding their way into longer term holdings reducing the available free float for short term trading.
Its getting tighter.
Now consider this, 7 days ago the run started and the free float has traded vigorously.
This free float trading volume has turned and the VWAP (average price) has increased on those shares.
Some of those shares have been lost to long term portfolios and will not trade anymore.
We are establishing a higher price for the reduced free float trading volume.
So, my conclusion is that the more this frenzy happens, the higher the share price saturation penetrates into the free float volume.
This company is rerating quickly.
RED
- Forums
- ASX - By Stock
- Ann: RCE Selected by CSIRO/PDI for SARS-CoV-2 Antiviral Program
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Here are a few thoughts from my side, by the way I've only been...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online